Home
5449 All Specialties
1422 Arthroplasty
536 Shoulder & Elbow
504 Sports Medicine
499 Spine
492 Trauma
476 Physical Therapy & Rehab
474 Osteoarthritis
291 Foot & Ankle
284 General Orthopaedics
254 Hand & Wrist
79 Metabolic Disorders
69 Pediatric Orthopaedics
48 Cannabis
21 Tumour
OE Plus
7 Ace Reviews
1 OE Recommends
73 OE Originals
60 OrthoPODS
24 OE World Tour NEW
43 Conferences
149 Exclusive Interviews
15 Evidence Series
CME
PeerView
Orthopaedic Surgeon
Primary Care Physician
Physiotherapist
Occupational Therapist
Sports Medicine Specialist
Orthopaedic Resident/Intern
Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Specialties

See all (14)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 2 results matching your search query: "Abaloparatide"

Showing 1 - 2 of 2
Read Ace Report

AAOS2018: Abaloparatide 80ug daily reduces rate of major NVFs in osteoporotic postmenopausal women

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Fracture Abaloparatide Placebo Subcutaneous Injection - Hide
Read Ace Report

WCO-IOF 2016: Daily subcutaneous abaloparatide vs teriparatide & placebo for osteoporosis

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Joint Vertebral Fracture Teriparatide Abaloparatide Placebo - Hide
Showing 1 - 2 of 2